Department of Dermatology, Turgut Ozal Medical Center, Inonu University, Malatya, Turkey.
Department of General Surgery, Turgut Ozal Medical Center, Liver Transplantation Institute, Inonu University, Malatya, Turkey.
J Cosmet Dermatol. 2021 Sep;20(9):2969-2974. doi: 10.1111/jocd.13944. Epub 2021 Jan 21.
In recent years, the number of liver transplantations for advanced-stage liver diseases has considerably increased and the patients have a wide range of dermatologic manifestations.
This study aims to reveal cutaneous, mucosal, and nail lesions in liver transplant recipients in quite large patient series.
PATIENTS/METHODS: The study included 520 patients in the Inonu University Liver Transplantation Institute. New and followed-up patients attended to the study between May and October 2019. The patients were examined by a dermatologist, and their data were recorded.
The study included 163 female and 357 male patients with the main age of 44.20 ± 18.18 (range: 1-83 years), and 465 livers (89.4%) were taken from live donors, while 54 livers (10.4%) were taken from cadavers. A total of 314 (60.4%) patients had dermatophyte infections, 174 (33.4%) patients had pathological nail changes, and 427 (82.1%) patients had oral mucosal lesions. Graft-versus-host disease (GVHD) developed in 9 (1.73%) patients after the transplantation, and 5 patients died of GVHD. Four patients had cutaneous malignancies.
Tumoral and nontumoral dermatological diseases may be encountered following the transplantation depending on underlying liver disease, immunosuppressive treatment, the graft itself, or any primary cutaneous disease. Liver transplantation recipients require a multidisciplinary clinical approach, and dermatological care must be an integral part of this approach.
近年来,晚期肝病的肝移植数量显著增加,患者表现出广泛的皮肤学表现。
本研究旨在揭示相当大规模的肝移植受者中皮肤、黏膜和甲的病变。
患者/方法:该研究纳入了因努大学肝移植研究所的 520 名患者。2019 年 5 月至 10 月期间,新患者和随访患者参加了该研究。由皮肤科医生对患者进行检查,并记录其数据。
本研究纳入了 163 名女性和 357 名男性患者,主要年龄为 44.20±18.18(范围:1-83 岁),465 个肝脏(89.4%)取自活体供者,而 54 个肝脏(10.4%)取自尸体。共有 314 名(60.4%)患者患有皮肤癣菌感染,174 名(33.4%)患者有病理指甲变化,427 名(82.1%)患者有口腔黏膜病变。移植后 9 名(1.73%)患者发生移植物抗宿主病(GVHD),5 名患者死于 GVHD。4 名患者患有皮肤恶性肿瘤。
根据潜在的肝病、免疫抑制治疗、移植物本身或任何原发性皮肤疾病,移植后可能会出现肿瘤性和非肿瘤性皮肤病。肝移植受者需要多学科的临床方法,皮肤护理必须是该方法的一个组成部分。